MedTrace Logo

Impact of the COVID-19 Pandemic on Central Precocious Puberty: a Retrospective Cohort Study from Turkey

NCT06823076 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 192

Last updated 2025-02-12

No results posted yet for this study

Summary

Objective: This study investigates the clinical and demographic characteristics of girls diagnosed with central precocious puberty (CPP) in the pre-pandemic and pandemic periods to assess potential changes during the COVID-19 pandemic.

Conditions

  • COVID19- Infection with SARS-CoV-2 Virus

Sponsors & Collaborators

  • Umraniye Education and Research Hospital

    lead OTHER_GOV

Eligibility

Max Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2022-03-01
Completion
2023-03-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06823076 on ClinicalTrials.gov